Visualitza HVH - Articles científics per autor "Oaknin Benzaquen, Ana Mazaltob"
Ara mostrant els elements 1-20 d 27
-
A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
Poveda, Andres; Oaknin Benzaquen, Ana Mazaltob; Romero, Ignacio; Guerrero‑Zotano, Angel; Fariñas Madrid, Lorena; Rodriguez‑Freixinos, Victor (Nature Research, 2021-02-24) -
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)
Monk, Bradley J.; Parkinson, Christine; Lim, Myong Cheol; O’Malley, David M.; Oaknin Benzaquen, Ana Mazaltob; Wilson, Michelle (Lippincott Williams & Wilkins, 2022-12-01) -
Advances in immunotherapy for cervical cancer
Grau-Bejar, Juan Francisco; Garcia-Duran, Carmen; García Illescas, David; Mirallas Viñas, Oriol; Oaknin Benzaquen, Ana Mazaltob (SAGE Publications, 2023-03-28) -
Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change?
Lorusso, Domenica; Ray-Coquard, Isabelle; Oaknin Benzaquen, Ana Mazaltob; Banerjee, Susana (BMJ, 2020-10-13) -
EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer
Oaknin Benzaquen, Ana Mazaltob; Monk, Bradley J.; de Melo, Andreia Cristina; Kim, Yong-Man; Lisyanskaya, Alla; Vergote, Ignace (Elsevier, 2022-10) -
Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials
Garralda Cabanas, Elena; Aguilar, Susana; Sala De Vedruna, Gemma; Viaplana Donato, Cristina; González-Zorelle, Jenifer; Grazia LoGiacco, Deborah; Ogbah, Zighereda; Mancuso, Francesco Mattia; Fasani, Roberta; Jiménez Flores, José Antonio; Martinez, Paola; Oaknin Benzaquen, Ana Mazaltob; Antunes de Melo Oliveira, Ana Mafalda; Balmaña Gelpí, Judith; Carles Galceran, Joan; Macarulla Mercadé, Teresa; Elez Fernandez, Mª Elena; Alsina Maqueda, Maria; Braña Garcia, Irene; Felip Font, Enriqueta; Tabernero Caturla, Josep; Rodon Ahnert, Jordi; Nuciforo, Paolo Giovanni; Vivancos Prellezo, Ana; Ramos Masdeu, Laia; Saura Manich, Cristina; Ruiz Pace, Fiorella; Dienstmann, Rodrigo (American Society of Clinical Oncology, 2020-05-14) -
Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study
Tewari, Krishnansu S.; Sill, Michael W.; Birrer, Michael J.; Penson, Richard; Huang, Helen; Moore, David H.; Oaknin Benzaquen, Ana Mazaltob (Elsevier, 2023-04) -
Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer
Rodriguez Freixinos, Victor; Fariñas Madrid, Lorena; Garrido-Castro, Ana Christina; Nuciforo, Paolo Giovanni; Vivancos Prellezo, Ana; Oaknin Benzaquen, Ana Mazaltob; Villacampa Javierre, Guillermo; Ruiz Pace, Fiorella; Dienstmann, Rodrigo (BMJ, 2019-03-08) -
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety
Oaknin Benzaquen, Ana Mazaltob; Oza, Amit M.; Lorusso, Domenica; Dean, Andrew; Colombo, Nicoletta; Aghajanian, Carol (Wiley, 2021-10) -
Management of advanced ovarian cancer in Spain: an expert Delphi consensus
Redondo Sanchez, Andres; Oaknin Benzaquen, Ana Mazaltob; Rubio, Maria Jesus; Barretina-Ginesta, Maria-Pilar; de Juan Ferre, Ana; Manso, Luis (BMC, 2021-05-26) -
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
Swisher, Elizabeth M.; Kwan, Tanya T.; Oza, Amit M.; Tinker, Anna V.; Ray-Coquard, Isabelle; Oaknin Benzaquen, Ana Mazaltob (Nature Research, 2021-05-03) -
Neratinib in patients with HER2 -mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial
Oaknin Benzaquen, Ana Mazaltob; Friedman, Claire F.; Roman, Lynda D.; D'Souza, Anishka; Braña Garcia, Irene; Bidard, François-Clement (Elsevier, 2020-10) -
Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)
Perez-Fidalgo, J. A.; Cortés, A.; Guerra, Eva; García, Y.; Iglesias, M.; Bohn Sarmiento, U.; Oaknin Benzaquen, Ana Mazaltob (Elsevier, 2021-08) -
Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis
Poveda, Andres; Lheureux, S.; Cibula, David; Weberpals, J.; Oaknin Benzaquen, Ana Mazaltob; Colombo, Nicoletta; Lindemann, Kristina (Elsevier, 2022-03) -
Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial
DiSilvestro, Paul; Kim, Byoung-Gie; Oaknin Benzaquen, Ana Mazaltob; Scambia, Giovanni; Banerjee, Susana; Colombo, Nicoletta (American Society of Clinical Oncology, 2023-01-20) -
Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma
Oza, Amit M.; Lorusso, Domenica; Oaknin Benzaquen, Ana Mazaltob; Dean, Andrew; Colombo, Nicoletta; Aghajanian, Carol (American Society of Clinical Oncology, 2020-10-20) -
Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study
Poveda, Andres; Oaknin Benzaquen, Ana Mazaltob; Redondo Sanchez, Andres; Rubio, Maria Jesus; Guerra, Eva; Fariñas Madrid, Lorena; Rodriguez Freixinos, Victor; López-Reig, Raquel (MDPI, 2022-02-12) -
Phase I prognostic online (PIPO): A web tool to improve patient selection for oncology early phase clinical trials
Matos Garcia, Ignacio; Hierro Carbó, Cinta; Martín Liberal, Juan Jesús; Berche, Roger; Pedrola Gómez, Anna; Braña Garcia, Irene; Azaro Pedrazzoli, Analía Beatriz; Vieito Villar, Maria; Saavedra Gadea, Omar; Gardeazabal, Itziar; Hernando Calvo, Alberto; Alonso-Casal, Guzman; Galvao De Aquiar, Vladimir; Ochoa de Olza Amat, Maria; Ros Montañá, Fco. Javier; Viaplana Donato, Cristina; Elez Fernandez, Mª Elena; Rodon Ahnert, Jordi; Macarulla Mercadé, Teresa; Oaknin Benzaquen, Ana Mazaltob; Carles Galceran, Joan; Felip Font, Enriqueta; Tabernero Caturla, Josep; Garralda Cabanas, Elena; Villacampa Javierre, Guillermo; Saura Manich, Cristina; Muñoz Couselo, Eva; Dienstmann, Rodrigo (Elsevier, 2021-09) -
Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer
O'Malley, David M.; Oaknin Benzaquen, Ana Mazaltob; Monk, Bradley J.; Selle, Frédéric; Rojas, Carlos; Gladieff, Laurence (Elsevier, 2021-11) -
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
Moore, Kathleen N; Oza, Amit M.; Oaknin Benzaquen, Ana Mazaltob; Lorusso, Domenica; Scambia, Giovanni; Colombo, Nicoletta (Elsevier, 2021-06)